Accelerating diagnostic access project
Now is the time to leverage the diagnostic advancements from the COVID-19 pandemic and build back better for AMR. In this video Professor Peeling tells us about a project rolled …
Course: Diagnostics for AMR: Building Back Better from the COVID-19 Pandemic
Data as a Public Good: building data systems and competency for AMR surveillance
For most countries that would like to invest in data and information and overall digital health for their health care system, it is likely that they may not have the …
WHO digital health initiative
Digital technologies have now become an important part of our daily lives. Throughout the pandemic, despite lock downs and border closures, we have never been more connected, thanks to innovations …
Genomic sequencing and predictions of susceptibility
Advances in whole genome sequencing and the application of online tools for real-time detection of AMR determinants is essential for control and prevention strategies to combat the increasing threat of …
The WHO AMR Technology landscape
In 2019, WHO published a landscape of diagnostics against antibacterial resistance, gaps and priorities. In this step, Dr. Debi Boeras goes through the types and methods of diagnostics, the diagnostic …
Making resistance data available for clinicians to improve patient care and conserve antibiotics for future generations
In this video we discuss digitising testing data and making resistance data available to clinicians, surgeons and others who prescribe antibiotics. Dr. Bill Rodriguez, the CEO of the Foundation for …
Updates on diagnostics and new treatment guidelines for TB
The WHO held an expert consultation on the definition of extensively drug-resistant tuberculosis on 27-29 October 2020, the outcomes can be summarized as follows: Unchanged definitions Rifampicin-resistant TB: TB caused …
Update on resistance trends for HAIs and blood stream infections
Hospitalised patients can often be at risk of acquiring health care associated bloodstream infections, particularly during the COVID-19 pandemic. In this step, Professor Rosanna Peeling looks at GLASS reporting on …
Welcome to Week 2
Dr. Noah Fongwen welcomes you to Week 2, where you will learn about the latest antimicrobial resistance trends and diagnostics used for clinical management to reduce inappropriate use of antimicrobials …
Innovations: MSF mini-lab
Before reading the article below, please watch this short video from Médecins Sans Frontières on the Mini-Lab access blue-print: This is an additional video, hosted on YouTube. Source: Jean-baptiste Ronat, …
Leveraging novel technologies for COVID-19 for a better AMR response
The COVID-19 pandemic has prompted numerous advances in diagnostic innovations and testing capacity. In this step, Dr. Debi Boeras discusses technology innovations, as well as the power of connectivity and …
Learning Objectives and Course Structure
By the end of this module, learners should be able to: understand the positive and negative impact that the COVID-19 pandemic has on the AMR response learn about how diagnostic …
Impact of the COVID-19 pandemic on AMR: views of experts from 4 countries
COVID-19 has disrupted many country programmes. In this video you will hear from four country experts on the impact of COVID-19 on their AMR programmes.
Impact of the COVID-19 pandemic on AMR and WHO guidance
In this step, Dr. Noah Fongwen shares findings from studies looking at the overuse of antibiotics for COVID-19 hospitalized patients.
Learning with us
If this is your first course with us, please read ‘Using FutureLearn’ for an introduction to learning with FutureLearn. We’re delighted that you’ve joined the course and wish you a …
These articles are from the online course:
Diagnostics for AMR: Building Back Better from the COVID-19 Pandemic